Index · Open funds
Seed venture funds investing in Biotech, New York
9 venture funds from 3 firms are raising or writing first checks for Seed-stage companies in Biotech, based in or investing in New York. Each fund qualifies by its stated focus or by deals it announced in the last 24 months.
9 funds
- 2048 Ventures III, LP$547K to $1.03M (estimated from fund size)Open, writing first checks
- USV 2024, LP$2.75M to $4.58M (estimated from fund size)Open, writing first checks
- USV Investors 2024, LP$69K to $114K (estimated from fund size)Open, writing first checks
- USV 2026, LP$5M to $8.33M (estimated from fund size)Raising
- 2048 Ventures II, LP$442K to $828K (estimated from fund size)Late investment period
- Swell Partners Fund II, L.P.$16K to $125K (estimated from fund size)Late investment period
Swell Partners, NY
- USV 2022, LP$2.75M to $4.58M (estimated from fund size)Late investment period
- USV Bundled 2022, LP$750K to $1.25M (estimated from fund size)Late investment period
- USV Bundled Investors 2022, LP$270K to $450K (estimated from fund size)Late investment period